tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vineet Laboratories Submits SEBI Compliance Certificate for Q2 2025

Story Highlights
Vineet Laboratories Submits SEBI Compliance Certificate for Q2 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Vineet Laboratories Ltd. ( (IN:VINEETLAB) ) is now available.

Vineet Laboratories Ltd. has submitted a compliance certificate in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the second quarter and half-year ending September 30, 2025. The certificate, issued by Venture Capital and Corporate Investments Private Limited, confirms that no securities were received for dematerialization or rematerialization during this period. This compliance indicates the company’s adherence to regulatory requirements, potentially reinforcing stakeholder confidence in its operational transparency.

More about Vineet Laboratories Ltd.

Vineet Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development and manufacture of chemical compounds and active pharmaceutical ingredients. The company is based in Hyderabad, India, and is listed on both the BSE and NSE stock exchanges.

Average Trading Volume: 8,833

Technical Sentiment Signal: Hold

Current Market Cap: 386M INR

For detailed information about VINEETLAB stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1